SKYE BIOSCIENCE INC (SKYE) Stock Earnings & Estimates
USA - NASDAQ:SKYE - US83086J2006 - Common Stock
1.3 USD
-0.07 (-5.11%)
1.3 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 411.29% | N/A 83.87% | ||||||||||||
| EBITDA YoY % growth | -2.73M | -4.31M -57.88% | -4.46M -3.48% | -3.85M 13.68% | -4.69M -21.82% | -6.63M -41.36% | -6.29M 5.13% | -7.82M -24.32% | -11.99M -53.32% | -34.763M -189.93% | -36.129M -3.93% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.73M | -4.32M -58.24% | -4.47M -3.47% | -3.86M 13.65% | -4.69M -21.50% | -6.63M -41.36% | -6.29M 5.13% | -7.85M -24.80% | -12.11M -54.27% | -34.887M -188.08% | -36.427M -4.42% | N/A -47.71% | N/A -4.67% | N/A -30.82% | N/A -34.05% | N/A -33.23% | N/A -21.19% | N/A 37.23% | N/A 62.00% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.72 87.00% | N/A -99.36% | N/A 12.86% | N/A -8.16% | N/A -70.39% | N/A -22.35% | N/A 3.62% | N/A 33.77% | N/A 49.86% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 -220.03% | -0.34 -41.10% | -0.32 -14.39% | -0.32 88.25% | -0.34 -5.18% | -0.36 -6.63% | -0.37 -14.65% | -0.38 -19.35% | -0.40 -18.18% | -0.42 -15.82% |
| Revenue Q2Q % growth | ||||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.341M -29.60% | -13.057M -5.75% | -14.756M -25.48% | -15.181M 16.79% | -15.946M -29.21% | -16.796M -28.63% | -11.73M 20.51% | -12.24M 19.37% | -13.005M 18.44% | -13.515M 19.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -2.69 -1,245.00% | -0.32 | -2.37 | -746.82% |
| Q1 2025 Q2Q % growth | -0.28 -55.56% | -0.29 | 0.01 | 4.35% |
| Q4 2024 Q2Q % growth | -0.24 61.90% | -0.29 | 0.05 | 17.20% |
| Q3 2024 Q2Q % growth | -0.10 | -0.26 | 0.16 | 60.89% |
| Q2 2024 Q2Q % growth | -0.20 | -0.20 | 0.00 | -0.55% |
| Q1 2024 Q2Q % growth | -0.18 | -0.16 | -0.02 | -10.29% |
| Q4 2023 Q2Q % growth | -0.63 | -0.39 | -0.24 | -62.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.96% | -3.26% | -15.76% |
| Revenue | N/A | N/A | N/A | N/A |